Everyday Benefits
Berberine With Ceylon Cinnamon: 11 of 18 Labels Hold 200 mg or Less

Key takeaways
- The only published placebo trial of the pair (Mansour 2025) gave 1,200 mg berberine and 600 mg cinnamon daily. With no berberine-alone arm, the cinnamon's share of the effect is unknown.
- Of 22 on-market labels pairing berberine with Ceylon cinnamon in the NIH Dietary Supplement Label Database, 18 state a cinnamon amount; 11 of those list 200 mg or less per serving.
- The most frequent formula, on 4 labels, is 1,200 mg berberine with 100 mg Ceylon cinnamon: one sixth of the cinnamon the combination trial used.
- The Cochrane review of cinnamon for diabetes found trials used mostly cassia, at a mean 2 g a day, and concluded the evidence was insufficient.
- Ceylon's selling point is its low coumarin. At 100 mg a day, even cassia would deliver a small fraction of Europe's tolerable daily intake, by our arithmetic.
Berberine with Ceylon cinnamon is one of the most common ways berberine is now sold. The pitch is synergy: two ingredients with a blood sugar reputation, one of them chosen in its “safe” form. We looked for the evidence that the pairing does more than berberine alone, and then read the labels to see how much cinnamon the capsules actually hold.
The one trial of the pair
A single placebo-controlled trial has tested berberine and cinnamon together. Published in the European Journal of Nutrition in 2025, it randomised people with type 2 diabetes in Tehran to “a divided daily dose of 1200 mg berberine and 600 mg cinnamon or placebo for 12 weeks.”
After 12 weeks, the combination group had lower fasting blood sugar (P = 0.031), HbA1c (P = 0.013) and LDL cholesterol (P = 0.039) than the placebo group. Total cholesterol, HDL and triglycerides did not differ, and nor did weight or the other measured markers.
The trial’s registry entry, NCT05570357, describes the capsule as 400 mg of berberine and 200 mg of “cinnamon extract” taken three times a day, against a maltodextrin placebo, with 44 people enrolled. It lists two arms and only two: the combination, and placebo. The abstract does not name the cinnamon species.
That design answers one question: does the pair beat a sugar pill? It cannot answer the one the product category rests on. Berberine on its own has lowered HbA1c in earlier trials, so a combination that beats placebo is what you would expect if the cinnamon did nothing at all. Showing that cinnamon adds something would need a berberine-only arm, and this trial did not have one.
What the labels hold
We searched the NIH Dietary Supplement Label Database for on-market products listing both berberine and cinnamon. There were 65, and 22 of them name Ceylon cinnamon.
Of those 22, 18 state how much cinnamon a serving contains. The amounts run from 0.2 mg to 2,200 mg:
| Cinnamon per serving | Labels |
|---|---|
| 200 mg or less | 11 |
| 300 to 500 mg | 2 |
| 600 mg or more | 5 |
| Amount not stated or hidden in a blend | 4 |
The most frequent formula, on 4 labels, is 1,200 mg of berberine with 100 mg of Ceylon cinnamon. That matches the trial’s berberine and carries one sixth of its cinnamon. One label lists its cinnamon as 200 mcg, a thousandth of a typical 200 mg dose. Another declares a 2,200 mg “Berberine Plus Ceylon Cinnamon Proprietary Blend” without saying how it splits.
So the label that names Ceylon cinnamon most prominently often contains the least of it. In most of these products, the cinnamon is closer to a flavouring than to a trial dose.
How strong is the cinnamon evidence anyway?
Not strong, and mostly not about Ceylon.
The Cochrane review of cinnamon for diabetes pooled 10 trials and 577 participants. The cinnamon was “predominantly Cinnamomum cassia” at “a mean dose of 2 g daily.” It found the effect on fasting glucose inconclusive, no significant difference in HbA1c, and concluded: “There is insufficient evidence to support the use of cinnamon for type 1 or type 2 diabetes mellitus.”
Later meta-analyses are more positive but no cleaner. A 2013 analysis of 10 trials found fasting glucose fell by 24.59 mg/dL while HbA1c did not change significantly, with heterogeneity between 66.5% and 94.72%. A 2025 analysis of 28 trials found HbA1c fell by 0.56, again with heterogeneity of 94%, meaning the trials disagreed with each other well beyond what chance would explain.
Ceylon has its own trials now, both from Sri Lanka:
- 150 adults with raised LDL, 1,000 mg a day of a standardised extract for 12 weeks. The main target, LDL, did not fall significantly (p = 0.161). Fasting blood sugar fell 8.59 mg/dL more than on placebo (p = 0.036), most clearly in people with type 2 diabetes.
- 210 people with type 2 diabetes, 250 mg or 500 mg of extract for four months. The abstract reports that fasting glucose and HbA1c “significantly declined in the CZ extract groups compared to baseline.” A fall from baseline is not the same as a difference from placebo, and the abstract does not give the between-group result for HbA1c.
Those trials used 250 mg to 1,000 mg of a standardised extract. Most combination capsules list 200 mg or less of cinnamon, usually without saying whether it is an extract or ground bark.
The coumarin argument, at capsule doses
Ceylon is chosen for one real reason: coumarin. Cassia cinnamon contains it in quantity, around 2.23 mg per gram in one analysis, while Ceylon holds under 0.01 mg per gram. Coumarin can harm the liver, and European regulators set a tolerable daily intake of 0.1 mg per kilogram of body weight. Germany’s risk assessment institute found that heavy consumers of cassia could reach that limit.
That is a real concern for someone stirring teaspoons of supermarket cinnamon into food every day. It is a small one at capsule doses. For a 70 kg adult the limit is 7 mg of coumarin a day. By our arithmetic, 100 mg of cassia at 2.23 mg per gram supplies about 0.22 mg, roughly 3% of that limit. Coumarin in cassia varies widely between samples, so treat this as an order of magnitude, not a guarantee.
The Ceylon premium buys the most protection at the doses the trials used. It buys the least at the 100 mg that most of these capsules contain.
Is it actually Ceylon?
The label cannot tell you. A European Commission study of 104 cinnamon samples bought at EU retailers found that 66.3% “either did not fulfil quality criteria set by international standards, were not compliant with European food safety legislation, were suspicious of fraud, or could be toxic for children due to a high content of coumarin.” Substituting cassia for Ceylon, the authors added, “was not the problem most frequently detected.”
A separate review of 276 Ceylon cinnamon labels found that the one property that distinguishes it, its very low coumarin content, was rarely stated on the label at all.
What this means if you are choosing one
If you want berberine for blood sugar, the berberine dose is what the evidence is about. The protocol behind its reputation, and the combination trial, both used 1,200 to 1,500 mg a day in divided doses. Our berberine supplement guide covers what that evidence shows and what it does not.
The cinnamon in most combination capsules is too small to match the trials, from a species that has only begun to be tested, in a combination tested once without the comparison that would show it helps. If a label hides the cinnamon amount inside a proprietary blend, you cannot compare it with anything.
Berberine also interacts with several common medicines and adds to the effect of glucose-lowering drugs. If you take any prescription medicine, especially for diabetes, raise it with the person who prescribes it before starting.
This article is for general information and is not a substitute for advice from a doctor or pharmacist who knows your medical history.
Frequently asked questions
Is berberine with Ceylon cinnamon better than berberine alone?
Nobody has tested that. The one published placebo-controlled trial of the combination, from Tehran, randomised people with type 2 diabetes to berberine plus cinnamon or to placebo. There was no group taking berberine alone, so the trial shows the pair beat a sugar pill, not that the cinnamon added anything to the berberine.
How much cinnamon is in a berberine and Ceylon cinnamon supplement?
Usually far less than the trials used. Of 18 on-market labels in the NIH database that state an amount, 11 list 200 mg or less per serving, and the most common formula pairs 1,200 mg of berberine with 100 mg of Ceylon cinnamon. Four more labels hide the amount in a blend or do not state it. The combination trial used 600 mg a day, and the Cochrane review's cinnamon trials averaged 2 g.
Why do supplements use Ceylon instead of regular cinnamon?
Because of coumarin, a compound that can harm the liver at high intakes. Cassia, the cheaper cinnamon sold in most supermarkets, is rich in it; Ceylon contains very little. Europe set a tolerable daily intake of 0.1 mg of coumarin per kilogram of body weight. That matters for someone eating teaspoons of cassia daily. At the 100 mg in a typical capsule, by our arithmetic, even cassia would supply a few percent of that limit.
Does Ceylon cinnamon lower blood sugar on its own?
Two recent Sri Lankan trials suggest a modest effect. In 150 adults with raised LDL, 1,000 mg a day of a standardised Ceylon extract lowered fasting glucose by 8.59 mg/dL more than placebo, with the clearest effect in people with diabetes, but did not significantly lower LDL. A second trial in 210 people with type 2 diabetes reported falls in fasting glucose and HbA1c from baseline on 250 mg and 500 mg of extract.
Is the cinnamon on the label really Ceylon?
You cannot tell from the label. A 2025 European Commission study of 104 cinnamon samples bought at EU retailers found 66.3% failed quality standards, breached food safety law, looked fraudulent, or held enough coumarin to be risky for children. Swapping cassia for Ceylon was not the most common problem it found.
Should I take berberine with cinnamon if I am on diabetes medicine?
Talk to whoever prescribes it first. Berberine lowered HbA1c in trials and can add to the effect of glucose-lowering drugs, and it slows enzymes that clear several common medicines. The combination trial enrolled people already managing type 2 diabetes, under supervision.
Sources
Every claim above is drawn from these primary sources. Last checked July 2026.
- 1.Mansour A, Sajjadi-Jazi SM, Gerami H, et al. The efficacy and safety of berberine in combination with cinnamon supplementation in patients with type 2 diabetes: a randomized clinical trial. European Journal of Nutrition. 2025;64(2):102. PMID 39998703. Parallel, double-blind, placebo-controlled; 'a divided daily dose of 1200 mg berberine and 600 mg cinnamon or placebo for 12 weeks'; FBS P = 0.031, HbA1c P = 0.013, LDL-C P = 0.039 against placebo; no difference in total cholesterol, HDL-C or triglycerides. Arms: berberine plus cinnamon, or placebo. One author employed by Pajoohesh Gostran Taghzie asan Company. Checked 3 November 2026
- 2.ClinicalTrials.gov NCT05570357, The Effects of Berberine and Cinnamon Supplementation on Diabetes Management. National Nutrition and Food Technology Institute, Iran. Two arms: 'Berberine+Cinnamon (TDS)', 'The supplements contains 400 mg Berberine, and 200 mg Cinnamon extract', versus maltodextrin placebo; actual enrollment 44; completed 10 February 2023. Checked 3 November 2026
- 3.Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database of Systematic Reviews. 2012;(9):CD007170. PMID 22972104. Ten RCTs, 577 participants; cinnamon 'predominantly Cinnamomum cassia' at 'a mean dose of 2 g daily' for 4 to 16 weeks; fasting glucose effect inconclusive; no significant difference in HbA1c; 'There is insufficient evidence to support the use of cinnamon for type 1 or type 2 diabetes mellitus.' Checked 3 November 2026
- 4.Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine. 2013;11(5):452-459. PMID 24019277. Ten RCTs, 543 patients, 120 mg/d to 6 g/d for 4 to 18 weeks; fasting plasma glucose -24.59 mg/dL; HbA1c -0.16% (95% CI -0.39 to 0.02), not significant; I2 66.5% to 94.72%. Checked 3 November 2026
- 5.de Moura SL, Gomes BGR, Guilarducci MJ, et al. Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis. Nutrition Reviews. 2025;83(2):249-279. PMID 38917435. 28 RCTs, 3,054 patients, 30 to 120 days; fasting glucose WMD -15.26 mg/dL (I2 88%); HbA1c WMD -0.56 (I2 94%); only doses of 2 g/day or less reduced HbA1c. Checked 3 November 2026
- 6.Muthukuda D, de Silva CK, Ajanthan S, Wijesinghe N, et al. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: a randomized, double-blind, controlled trial. PLoS One. 2025;20(1):e0317904. PMID 39854533. 150 participants with LDL 100-190 mg/dL; 1000 mg/day extract or placebo for 12 weeks; LDL difference 6.05 mg/dL, p = 0.161, not significant; fasting blood sugar adjusted mean difference 8.59 mg/dL, p = 0.036; larger effect in type 2 diabetes. Checked 3 November 2026
- 7.Ranasinghe P, Galappatthy P, Constantine GR, Jayawardena R, et al. Efficacy and Safety of Cinnamomum zeylanicum (Ceylon cinnamon) for diabetes mellitus: a randomized, double blind, placebo-controlled trial. Diabetes & Metabolic Syndrome. 2025;19(12):103357. PMID 41412108. 210 people with type 2 diabetes randomised to 250 mg or 500 mg extract or placebo; 186 completed four months; abstract reports FPG and HbA1c 'significantly declined in the CZ extract groups compared to baseline'; LDL and total cholesterol lower in the 500 mg group. Checked 3 November 2026
- 8.Abraham K, Wöhrlin F, Lindtner O, Heinemeyer G, Lampen A. Toxicology and risk assessment of coumarin: focus on human data. Molecular Nutrition & Food Research. 2010;54(2):228-239. PMID 20024932. Tolerable daily intake of 0.1 mg/kg body weight (EFSA, confirmed with human data); exposure 'mainly due to use of cassia cinnamon'; heavy consumers of cassia may reach the TDI. Checked 3 November 2026
- 9.De Silva DAM, et al. Clean vs dirty labels: Transparency and authenticity of the labels of Ceylon cinnamon. PLoS One. 2021;16(11):e0260474. PMID 34813609. 276 labels analysed; Ceylon coumarin 'ultra-low level (<0.01 mg/g Dry Weight)', rarely stated on labels; cassia 'Coumarin content 2.23 mg/g DW'. Checked 3 November 2026
- 10.Ghidotti M, Behr M, Pietretti D, Jiménez M, et al. High rate of safety and fraud issues in commercially available cinnamon. NPJ Science of Food. 2025;9(1):125. PMID 40617844. 104 samples from EU retailers; '66.3%, either did not fulfil quality criteria set by international standards, were not compliant with European food safety legislation, were suspicious of fraud, or could be toxic for children due to a high content of coumarin'; Ceylon-to-cassia substitution 'was not the problem most frequently detected'. Checked 3 November 2026
- 11.NIH Office of Dietary Supplements, Dietary Supplement Label Database (DSLD) API v9, searches 'berberine ceylon cinnamon' and 'berberine cinnamon', on-market labels listing both berberine and cinnamon: 65, of which 22 name Ceylon (Cinnamomum verum or zeylanicum). Of those 22, 18 state a cinnamon amount: 0.2, 20, 50, 75, 100, 100, 100, 100, 150, 200, 200, 300, 500, 600, 750, 750, 1000 and 2200 mg per serving; 11 at 200 mg or less, 5 at 600 mg or more. Most frequent pair 1,200 mg berberine with 100 mg Ceylon cinnamon (4 labels, e.g. 266149, 268752, 331358, 331353). Label 336925 lists a 2200 mg 'Berberine Plus Ceylon Cinnamon Proprietary Blend'. Our own count, 3 November 2026
- 12.Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PMID 18442638. Berberine 0.5 g three times a day (1,500 mg a day); 'hypoglycemic effect of berberine was similar to that of metformin'. Checked 3 November 2026
- 13.Our arithmetic, not a published figure: the 0.1 mg/kg tolerable daily intake for a 70 kg adult is 7 mg of coumarin a day; 100 mg of cassia at 2.23 mg/g supplies about 0.22 mg, roughly 3% of 7 mg. Ceylon trial doses 250 mg to 1,000 mg; DSLD label range 0.2 mg to 2,200 mg.